(19)
(11) EP 3 911 372 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.01.2023 Bulletin 2023/01

(45) Mention of the grant of the patent:
30.11.2022 Bulletin 2022/48

(21) Application number: 20700204.9

(22) Date of filing: 09.01.2020
(51) International Patent Classification (IPC): 
A61K 51/04(2006.01)
C07B 59/00(2006.01)
 A61K 101/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 51/0406; C07B 59/001
(86) International application number:
PCT/EP2020/050406
(87) International publication number:
WO 2020/148154 (23.07.2020 Gazette 2020/30)

(54)

COMPOUND TARGETING NOREPINEPHRINE TRANSPORTER

AUF NOREPINEPHRINTRANSPORTER ABZIELENDE VERBINDUNG

COMPOSÉ CIBLANT LE TRANSPORTEUR DE NORÉPINÉPHRINE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 17.01.2019 EP 19152274

(43) Date of publication of application:
24.11.2021 Bulletin 2021/47

(73) Proprietor: Beijing Lado Technology Co. Ltd.
Beijing, 100082 (CN)

(72) Inventors:
  • DECKER, Michael
    97074 Würzburg (DE)
  • HIGUCHI, Takahiro
    97080 Würzburg (DE)
  • CHEN, Xinyu
    97078 Würzburg (DE)

(74) Representative: Vos, Derk 
Maiwald GmbH Elisenhof Elisenstraße 3
80335 München
80335 München (DE)


(56) References cited: : 
WO-A2-2008/083056
 WO-A2-2013/036869
   
  • GANESAN VAIDYANATHAN ET AL: "Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG", NUCLEAR MEDICINE AND BIOLOGY., vol. 42, no. 8, 1 August 2015 (2015-08-01) , pages 673-684, XP055604085, US ISSN: 0969-8051, DOI: 10.1016/j.nucmedbio.2015.04.005 cited in the application
  • R. A. WERNER ET AL: "Retention Kinetics of the 18F-Labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-Hydroxyephedrine and 123I-MIBG", THE JOURNAL OF NUCLEAR MEDICINE, vol. 56, no. 9, 16 July 2015 (2015-07-16), pages 1429-1433, XP055382282, US ISSN: 0161-5505, DOI: 10.2967/jnumed.115.158493 cited in the application
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).